The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Antiarrhythmic Drug Therapy for Atrial Fibrillation
Abstract
A ntiarrhythmic medications have been available for nearly 100 years and remain a mainstay in the management of atrial fibrillation (AF).Goals of therapy with the use of these drugs include a reduction in the frequency and duration of episodes of arrhythmia as well an emerging goal of reducing mortality and hospitalizations associated with AF.The use of these drugs has been limited by both proarrhythmic and noncardiovascular toxicities as well as often modest antiarrhythmic efficacy.Despite these limitations, antiarrhythmic drugs remain widely prescribed for the management of symptomatic AF, and a host of new antiarrhythmic drugs are in various stages of clinical development.This review will focus primarily on antiarrhythmic drug use in patients with AF in the absence of significant structural heart disease or congestive heart failure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Developed with the special contribution of the European Heart Rhythm Association (EHRA), Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS), Authors/Task Force Members, Camm, A. J., Kirchhof, P., Lip, G. Y. H., Schotten, U., Savelieva, I., Ernst, S., Van Gelder, I. C., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq278 · Cited by 5,864
A comparison of rate control and rhythm control in patients with atrial fibrillation
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa021328 · Cited by 4,405
Echt, D. S., Liebson, P. R., Mitchell, L. B., Peters, R. W., Obias-Manno, D., Barker, A. H., Arensberg, D., Baker, A., Friedman, L., Greene, H. L., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103213241201 · Cited by 3,253
Van Gelder, I. C., Hagens, V. E., Bosker, H. A., Kingma, J. H., Kamp, O., Kingma, T., Said, S. A., Darmanata, J. I., Timmermans, A. J. M., Tijssen, J. G. P., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021375 · Cited by 2,359
Wann, L. S., Curtis, A. B., January, C. T., Ellenbogen, K. A., Lowe, J. E., Estes, N. A. M., Page, R. L., Ezekowitz, M. D., Slotwiner, D. J., Jackman, W. M., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3181fa3cf4 · Cited by 1,336
Amiodarone to Prevent Recurrence of Atrial Fibrillation
Roy, D., Talajic, M., Dorian, P., Connolly, S., Eisenberg, M. J., Green, M., Kus, T., Lambert, J., Dubuc, M., Gagné, P., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003303421302 · Cited by 1,143
Hohnloser, S. H., Kuck, K.-H., & Lilienthal, J. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03230-x · Cited by 1,134
Effect of Dronedarone on Cardiovascular Events in Atrial Fibrillation
Hohnloser, S. H., Crijns, H. J. G. M., van Eickels, M., Gaudin, C., Page, R. L., Torp-Pedersen, C., & Connolly, S. J. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0803778 · Cited by 1,129
Dofetilide in Patients with Congestive Heart Failure and Left Ventricular Dysfunction
Torp-Pedersen, C., Møller, M., Bloch-Thomsen, P. E., Køber, L., Sandøe, E., Egstrup, K., Agner, E., Carlsen, J., Videbæk, J., Marchant, B., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909163411201 · Cited by 1,012
Increased Mortality after Dronedarone Therapy for Severe Heart Failure
Køber, L., Torp-Pedersen, C., McMurray, J. J. V., Gøtzsche, O., Lévy, S., Crijns, H., Amlie, J., & Carlsen, J. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0800456 · Cited by 972
Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation
Carlsson, J. Ö., Miketic, S., Windeler, J. Ü., Cuneo, A., Haun, S., Micus, S., Walter, S., & Tebbe, U. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00332-2 · Cited by 941
Wachtell, K., Lehto, M., Gerdts, E., Olsen, M. H., Hornestam, B., Dahlöf, B., Ibsen, H., Julius, S., Kjeldsen, S. E., Lindholm, L. H., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.10.068 · Cited by 826
Amiodarone versus sotalol for atrial fibrillation
Singh, B. N., Singh, S. N., Reda, D. J., Tang, X. C., Lopez, B., Harris, C. L., Fletcher, R. D., Sharma, S. C., Atwood, J. E., Jacobson, A. K., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa041705 · Cited by 749
Dronedarone for Maintenance of Sinus Rhythm in Atrial Fibrillation or Flutter
Singh, B. N., Connolly, S. J., Crijns, H. J. G. M., Roy, D., Kowey, P. R., Capucci, A., Radzik, D., Aliot, E. M., & Hohnloser, S. H. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa054686 · Cited by 631
Patti, G., Chello, M., Candura, D., Pasceri, V., D’Ambrosio, A., Covino, E., & Di Sciascio, G. (2006) · Circulation · doi:10.1161/circulationaha.106.621763 · Cited by 617
Dronedarone in High-Risk Permanent Atrial Fibrillation
Connolly, S. J., Camm, A. J., Halperin, J. L., Joyner, C., Alings, M., Amerena, J., Atar, D., Avezum, Á., Blomström, P., Borggrefe, M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1109867 · Cited by 544
Efficacy of Quinidine in High-Risk Patients With Brugada Syndrome
Belhassen, B., Glick, A., & Viskin, S. (2004) · Circulation · doi:10.1161/01.cir.0000143159.30585.90 · Cited by 494
Roden, D. M., Woosley, R. L., & Primm, R. K. (1986) · American Heart Journal · doi:10.1016/0002-8703(86)90010-4 · Cited by 488
Stambler, B. S., Wood, M. A., Ellenbogen, K. A., Perry, K. T., Wakefield, L. K., & VanderLugt, J. T. (1996) · Circulation · doi:10.1161/01.cir.94.7.1613 · Cited by 486
Outpatient treatment of recent-onset atrial fibrillation with the “Pill-in-the-Pocket” approach
Alboni, P., Botto, G. L., Baldi, N., Luzi, M., Russo, V., Gianfranchi, L., Marchi, P., Calzolari, M., Solano, A., Baroffio, R., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041233 · Cited by 479
Rate Control vs Rhythm Control in Patients With Nonvalvular Persistent Atrial Fibrillation
Opolski, G., Torbicki, A., Kosior, D. A., Szulc, M., Wozakowska-Kapłon, B., Kołodziej, P., & Achremczyk, P. (2004) · Chest · doi:10.1378/chest.126.2.476 · Cited by 473
Scirica, B. M., Morrow, D. A., Hod, H., Murphy, S. A., Belardinelli, L., Hedgepeth, C. M., Molhoek, P., Verheugt, F. W. A., Gersh, B. J., McCabe, C. H., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.724880 · Cited by 445
Valsartan for prevention of recurrent atrial fibrillation
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0805710 · Cited by 441
Singh, S., Zoble, R. G., Yellen, L., Brodsky, M. A., Feld, G. K., Berk, M., & Billing, C. B. (2000) · Circulation · doi:10.1161/01.cir.102.19.2385 · Cited by 433
Prevention of Atrial Fibrillation by Renin-Angiotensin System Inhibition
Schneider, M. P., Hua, T. A., Böhm, M., Wachtell, K., Kjeldsen, S. E., & Schmieder, R. E. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.01.043 · Cited by 417
Sherrid, M. V., Barac, I., McKenna, W. J., Elliott, P. M., Dickie, S., Chojnowska, L., Casey, S., & Maron, B. J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.012 · Cited by 410
Wann, L. S., Curtis, A. B., Ellenbogen, K. A., Estes, N. A. M., Ezekowitz, M. D., Jackman, W. M., January, C. T., Lowe, J. E., Page, R. L., Slotwiner, D. J., et al. (2011) · Circulation · doi:10.1161/cir.0b013e31820f14c0 · Cited by 399
LE HEUZEY, J., DE FERRARI, G. M., RADZIK, D., SANTINI, M., ZHU, J., & DAVY, J. (2010) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2010.01764.x · Cited by 386
Køber, L., Thomsen, P. E. B., Møller, M., Torp-Pedersen, C., Carlsen, J., Sandøe, E., Egstrup, K., Agner, E., Videbæk, J., Marchant, B., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03402-4 · Cited by 338
Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial
FETSCH, T. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.04.015 · Cited by 334
Valsartan for Prevention of Recurrent Atrial Fibrillation
(2009) · New England Journal of Medicine · doi:10.1056/nejmx090019 · Cited by 328
Roy, D., Pratt, C. M., Torp-Pedersen, C., Wyse, D. G., Toft, E., Juul-Moller, S., Nielsen, T., Rasmussen, S. L., Stiell, I. G., Coutu, B., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.723866 · Cited by 322
Savelieva, I., Kakouros, N., Kourliouros, A., & Camm, A. J. (2011) · Europace · doi:10.1093/europace/eur002 · Cited by 312
Camm, A. J., Capucci, A., Hohnloser, S. H., Torp-Pedersen, C., Van Gelder, I. C., Mangal, B., & Beatch, G. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.07.046 · Cited by 274
Galve, E., Rius, T., Ballester, R., Artaza, M. A., Arnau, J. M., García-Dorado, D., & Soler-Soler, J. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00595-1 · Cited by 263
Connolly, S. J., Crijns, H. J. G. M., Torp-Pedersen, C., van Eickels, M., Gaudin, C., Page, R. L., & Hohnloser, S. H. (2009) · Circulation · doi:10.1161/circulationaha.109.875252 · Cited by 261
Freemantle, N., Lafuente-Lafuente, C., Mitchell, S., Eckert, L., & Reynolds, M. (2011) · Europace · doi:10.1093/europace/euq450 · Cited by 245
Amiodarone for Atrial Fibrillation
Zimetbaum, P. (2007) · New England Journal of Medicine · doi:10.1056/nejmct065916 · Cited by 213
Self-citationKowey, P. R., Dorian, P., Mitchell, L. B., Pratt, C. M., Roy, D., Schwartz, P. J., Sadowski, J., Sobczyk, D., Bochenek, A., & Toft, E. (2009) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.109.870204 · Cited by 193
Shimizu, W., Ohe, T., Kurita, T., Kawade, M., Arakaki, Y., Aihara, N., Kamakura, S., Kamiya, T., & Shimomura, K. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00313-4 · Cited by 164
Effects of amiodarone therapy on thyroid function
Cohen-Lehman, J., Dahl, P., Danzi, S., & Klein, I. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.225 · Cited by 157
Huang, D. T.-C., Monahan, K. M., ZIMETBAUM, P. J., PAPAGEORGIOU, P., MEpstein, L., & Josephson, M. E. (1998) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.1998.tb01837.x · Cited by 153
Self-citationSynergistic Effect of the Combination of Ranolazine and Dronedarone to Suppress Atrial Fibrillation
Burashnikov, A., Sicouri, S., Diego, J. M. D., Belardinelli, L., & Antzelevitch, C. N. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.08.600 · Cited by 131
ORTH, P., HESKETH, J., MAK, C., YANG, Y., Lin, S., Beatch, G. N., Ezrin, A. M., & Fedida, D. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.01.026 · Cited by 120
Wu, L., Ma, J., Li, H., Wang, C., Grandi, E., Zhang, P., Luo, A., Bers, D. M., Shryock, J. C., & Belardinelli, L. (2011) · Circulation · doi:10.1161/circulationaha.110.000661 · Cited by 103
Kozhevnikov, D., Yamamoto, K., Robotis, D. A., Restivo, M., & El‐Sherif, N. (2002) · Circulation · doi:10.1161/hc0902.104711 · Cited by 91
Krishnan, S., & Josephson, M. E. (1998) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.1998.tb00088.x · Cited by 89
Role of late sodium current in modulating the proarrhythmic and antiarrhythmic effects of quinidine
Wu, L., Guo, D., Li, H., Hackett, J. R., Yan, G., Jiao, Z., Antzelevitch, C. N., Shryock, J. C., & Belardinelli, L. (2008) · Heart Rhythm · doi:10.1016/j.hrthm.2008.09.008 · Cited by 83
Sicouri, S., Burashnikov, A., Belardinelli, L., & Antzelevitch, C. N. (2009) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.109.886275 · Cited by 76
Bioavailability of amiodarone tablets administered with and without food in healthy subjects
Xu, M. J., Mojaverian, P., Doedée, M., Lin, E. T., Weinryb, I., Chiang, S. T., & Kowey, P. R. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)01396-5 · Cited by 73
Nabar, A., Rodriguez, L., Timmermans, C. C., van Mechelen, R., & Wellens, H. J. J. (2001) · Heart · doi:10.1136/heart.85.4.424 · Cited by 72
Hauser, T. H., Pinto, D. S., Josephson, M. E., & ZIMETBAUM, P. J. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00395-3 · Cited by 69
Self-citationKaufman, E. S., Zimmermann, P. A., Wang, T., Dennish, G. W., Barrell, P., Chandler, M. L., & Greene, H. L. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.06.052 · Cited by 67
Amiodarone Interacts with Simvastatin but not with Pravastatin Disposition Kinetics
Becquemont, L., Neuvonen, M., Verstuyft, C., Jaillon, P., Letierce, A., Neuvonen, P. J., & Funck‐Brentano, C. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100098 · Cited by 64
Essebag, V., Reynolds, M. R., Hadjis, T., Lemery, R., Olshansky, B., Buxton, A. E., Josephson, M. E., & Zimetbaum, P. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.15.1648 · Cited by 50
Self-citationArya, A., Silberbauer, J., Teichman, S. L., Milner, P., Sulke, N., & Camm, A. J. (2008) · EP Europace · doi:10.1093/europace/eun384 · Cited by 37
Martin‐Doyle, W., Essebag, V., ZIMETBAUM, P. J., & REYNOLDS, M. R. (2010) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2010.01950.x · Cited by 28
Self-citationZIMETBAUM, P. J., Schreckengost, V. E., Cohen, D. J., Lemery, R., Love, D., Epstein, L. M., Laham, R. J., & Josephson, M. E. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00885-6 · Cited by 26
Self-citationAn Argument for Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation
ZIMETBAUM, P. J. (2005) · Circulation · doi:10.1161/circulationaha.104.537175 · Cited by 24
Self-citation
Cited by
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström-Lundqvist, C., Boriani, G., Castella, M., Dan, G.-A., Dilaveris, P. E., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa612 · Cited by 9,971
January, C. T., Wann, L. S., Alpert, J. S., Calkins, H., Cigarroa, J. E., Cleveland, J. C., Conti, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000041 · Cited by 7,115
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
January, C. T., Wann, L. S., Alpert, J. S., Calkins, H., Cigarroa, J. E., Cleveland, J. C., Conti, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.03.022 · Cited by 2,955
Andrade, J. G., Aguilar, M., Atzema, C., Bell, A., Cairns, J. A., Cheung, C. C., Cox, J. L., Dorian, P., Gladstone, D. J., Healey, J. S., et al. (2020) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2020.09.001 · Cited by 562
Spatially resolved multiomics of human cardiac niches
Kanemaru, K., Cranley, J., Muraro, D., Miranda, A. M. A., Ho, S. Y., Wilbrey-Clark, A., Patrick Pett, J., Polanski, K., Richardson, L., Litvinukova, M., et al. (2023) · Nature · doi:10.1038/s41586-023-06311-1 · Cited by 425
Metadata
- Authors
- Zimetbaum, P.
- Venue
- Circulation
- Published
- 2012-01-17
- Volume
- 125
- Issue
- 2
- Pages
- 381-389
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2170603740
- Cited by
- 277
- References
- 59
- FWCI
- 12.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.